Enterococci are a part of the normal microbial flora in the gastrointestinal tracts of humans, animals and birds. The major enterococcal species include *Enterococcus faecalis*, *Enterococcus faecium* and *Enterococcus durans*\[[@r1], [@r2], [@r15]\]. Enterococci do not cause illness in healthy humans or animals. However, they have recently been recognized as opportunistic nosocomial pathogens that cause infections of the urinary tract and central nervous system and lead to endocarditis and bacteremia \[[@r4], [@r10]\]. In addition, enterococci can rapidly acquire antimicrobial resistance through mutations or acquisition of plasmids and transposons that contain foreign genetic material, including vancomycin-resistance genes \[[@r7], [@r11]\]. Outbreaks of vancomycin-resistant enterococci (VRE) in humans may be associated with VRE in livestock, although the transmission mechanisms remain unclear.

Numerous reports have described the transmission of pathogenic and/or antimicrobial-resistant bacteria from companion animals to their owners \[[@r3], [@r18]\]. Therefore, monitoring drug-resistant and pathogenic bacteria in companion animals has become important for public health and veterinary medicine. However, few studies have reported the presence of enterococci in companion animals in Japan or elsewhere \[[@r13], [@r14], [@r16], [@r21]\].

We previously conducted an epidemiological survey of enterococci in companion dogs and cats in Japan \[[@r16]\]. In particular, several enterococci species that were resistant to ampicillin (ABPC) and enrofloxacin (ERFX) were detected in a group under antibiotic selective pressure, while VRE harboring *vanA* or *vanB* were not detected. Subsequently, we surveyed the antimicrobial susceptibility of enterococci in antibiotic-treated dogs and cats. The objective of this study was to examine the antimicrobial susceptibility of enterococci isolated from dogs and cats during 2011--2012.

Fecal swabs were collected from 84 dogs and 16 cats (\>2 years old) that had been treated with antibiotics (penicillins, 13/100; cephalosporins, 53/100; aminoglycosides, 4/100; quinolones, 31/100; and macrolides, 2/100) at the Nippon Veterinary and Life Science University Animal Medical Center from 2011 to 2012. All the samples were plated on Enterococcosel agar (Becton, Dickinson and Co., Tokyo, Japan) and were incubated aerobically at 37°C for 48 hr. For each plate, 1 colony with the morphological characteristics of enterococci (i.e., dark brown halo) was initially tested by Gram staining, growth in 6.5% NaCl broth and bile esculin hydrolysis. The identities of these enterococci were then confirmed using API STREP 20 (bioMerieux Japan Ltd., Tokyo, Japan) and polymerase chain reaction (PCR) \[[@r16]\].

Minimum inhibitory concentrations (MICs) were determined using a microdilution test according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement. Villanova, PA: CLSI; 2005 Publication No. M100-S15). The following 10 antibiotics were tested: ABPC, dihydrostreptomycin (DSM), gentamicin (GM), kanamycin (KM), erythromycin (EM), lincomycin (LCM), oxytetracycline (OTC), chloramphenicol (CP), ERFX and vancomycin (VCM). Two-fold dilutions of each antibiotic were prepared to obtain final concentrations from 512 mg/*l* to 0.125 mg/*l*. MIC breakpoints were set according to CLSI guidelines. Isolates were considered resistant when MICs for ABPC, DSM, GM, KM, EM, LCM, OTC, CP, ERFX and VCM were greater than or equal to 16, 128, 32, 128, 8, 128, 16, 32, 4 and 32 mg/*l*, respectively. *E. faecalis* ATCC 29212 was used as a control microorganism for each set of tests.

Presence of the resistance genes *vanA*, *vanB*, *vanC1* and *vanC2/C3* was examined for all enterococcal strains by PCR, as described by Clark *et al*. \[[@r6]\], Dutka-Malen *et al*. \[[@r9]\] and Satake *et al*. \[[@r19]\], with previously described modifications \[[@r16]\]. PCR products were analyzed by agarose gel electrophoresis. *E. faecium* ATCC 51559 (*vanA*- harboring reference strain), *E. faecalis* ATCC 51299 (*vanB*), *Enterococcus gallinarum* ATCC 49573 (*vanC1*) and *Enterococcus casseliflavus* ATCC 25788 (*vanC2/3*) were used as VRE controls.

Enterococci were isolated from 70 of 84 dogs (83.3%) and 7 of 16 cats (43.8%) ([Table 1](#tbl_001){ref-type="table"}Table 1.*Enterococcus* species isolated from dogs and catsBacterial speciesDogsCatsTotalsType of *van* gene*Enterococcus faecalis*46450 (64.9%)*E. faecium*11314 (18.2%)*E. gallinarum*101 (1.3%)VanC1*E. casseliflavus*303 (3.9%)VanC2/3*E. avium*202 (2.6%)*E. durans*505 (6.5%)Others202 (2.6%)Totals70777). The distribution of species among the 77 enterococcal isolates was as follows: *E. faecalis* (50/77; 64.9%), *E. faecium* (14/77; 18.2%) and *E. durans* (5/77; 6.5%). The remaining two strains were not identified with the API STREP 20 system. In most previous studies on enterococci from dogs and cats, *E. faecalis* and *E. faecium* were the predominant species \[[@r19], [@r20]\].

Antibiotic susceptibility results are summarized in [Fig. 1](#fig_001){ref-type="fig"}Fig 1.Antibiotic resistant isolates of enterococci isolated from dogs and cats.. Resistance to EM and OTC was detected in 44.2% of the 77 enterococci isolates. Resistance to GM and KM was detected in\>30% of isolates. In contrast, resistance to ABPC and ERFX was detected in 3.9% and 13.0% of all isolates, respectively. *E. faecium* isolates exhibited higher resistance to KM and ERFX than *E. faecalis*. Compared with a previous survey \[[@r16]\], resistance to DSM, GM, EM and CP was not different in this study; however, significant changes were observed in resistance to ABPC and ERFX. Although it was uncertain why the susceptibility to ABPC and ERFX was restored, it was possible that increased use of recently marketed third-generation cephalosporins for small animals accounted for the reduced occurrence of resistance to quinolones and penicillins.

Delgado *et al.* reported on the antimicrobial susceptibility patterns among veterinary clinical enterococci isolated from dogs and cats \[[@r8]\]. In their results, susceptibility was high to ABPC (95.5%), and resistance was high to TC (67.3%) and EM (50.9%). Cinquepalmi *et al.* reported that enterococci isolated from dog feces were resistant to TC (65.7%), EM (60.3%), ABPC (47.9%) and levofloxacin (23.3%) \[[@r5]\]. Thus, our results were in agreement with their results that many of the enterococci isolated from companion animals were resistant to TC and EM. We found no resistance to VCM, which was consistent with a number of studies on enterococci from dogs and cats \[[@r8], [@r17], [@r20]\].

The resistance patterns of 77 enterococcal isolates are shown in [Table 2](#tbl_002){ref-type="table"}Table 2.Antibiotic-resistant patterns of enterococci from dogs and catsNumber of antibiotics to\
which resistance was shownAntibiotic resistance patternNumber of\
strainsSpeciesNumber of animalsDogsCats9ABPC, DSM, GM, KM, EM, LCM, OTC, CP, ERFX1*E. gallinarum*18ABPC, DSM, GM, KM, EM, LCM, CP, ERFX1*E. faecium*17DSM, GM, KM, EM, LCM, OTC, CP2*E. faecalis*2GM, KM, EM, LCM, OTC, CP, ERFX1*E. faecalis*16DSM, GM, KM, EM, LCM, OTC3*E. faecalis*3DSM, KM, EM, LCM, OTC, CP1*E. faecalis*1DSM, KM, EM, LCM, OTC, ERFX2*E. faecalis*1*E. faecium*1GM, KM, EM, LCM, OTC, CP1*E. faecalis*15DSM, EM, LCM, OTC, CP2*E. faecalis*2GM, KM, EM, LCM, CP1*E. durans*1GM, KM, EM, LCM, OTC1*E. faecalis*1GM, EM, LCM, OTC, CP1*E. faecalis*14ABPC, EM, LCM, OTC1*E. faecalis*1DSM, EM, LCM, CP2*E. faecalis*2DSM, EM, OTC, CP1*E. faecalis*1GM, EM, LCM, OTC1*E. faecalis*1EM, LCM, OTC, CP1*E. faecalis*13DSM, GM, LCM1*E. faecalis*1DSM, GM, OTC2*E. faecalis*2DSM, GM, ERFX1*E. faecalis*1DSM, KM, OTC1*E. faecalis*1DSM, EM, CP1*E. faecalis*1DSM, EM, LCM1*E. faecium*1DSM, OTC, CP1*E. faecalis*1GM, KM, OTC1*E. faecalis*1KM, EM, LCM2*E. faecalis*2KM, OTC, ERFX1*E. faecium*1EM, LCM, OTC3*E. faecalis*11*E.casseliflavus*1EM, LCM, CP1*E. faecalis*12GM, KM1*E. faecalis*1KM, ERFX1*E. faecium*1EM, LCM2*E. faecium*1*E. avium*1EM, OTC1*E. faecalis*11GM5*E. faecalis*3*E. faecium*2KM3*E. faecalis*1*E. faecium*2OTC5*E. faecalis*4*E. durans*1ERFX2*E. faecalis*1*E. faecium*10Susceptive18*E. faecalis*61*E. faecium*21*E.casseliflavus*2*E. durans*3*E. avium*1Others2Totals77707. Eighteen (23.4%) isolates were susceptible to all antibiotics tested. A total of 15 strains (19.5%) exhibited resistance to a single antimicrobial agent, and multidrug resistance (MDR; resistance to ≥2 antimicrobial agents) was detected in 44 of 77 isolates (57.1%). In particular, MDR of isolates from dogs (39 of 70; 50.6%) was remarkable. Poeta *et al.* reported similar results that susceptible strains to all tested antibiotics were isolated from 31.0% of dogs and cats in Portugal \[[@r19]\]. However, they also reported that the proportion of enterococci isolated from poultry that is susceptible to antimicrobial agents is extremely low (0.7%). Compared with the susceptibility of enterococci from poultry, it appears that the enterococci from dogs and cats are more susceptible to antibiotics.

One strain of *E. gallinarum* harboring *vanC1* and 3 strains of *E. casseliflavus* harboring *vanC2/3* were found among our isolates ([Table 1](#tbl_001){ref-type="table"}). In our previous study, enterococci that harbored *vanC1* and *VanC2/3* genes were isolated from only 1 of 29 (3.4%) antibiotic-treated dogs and cats \[[@r16]\]. These results demonstrated that VRE were rarely colonized in dogs and cats.

In conclusion, comparing the results of the present study with those of a previous study revealed a difference in the frequency of antimicrobial resistance among enterococci isolated from antibiotic-treated companion animals. This might reflect a change in the use of antimicrobials for companion animals \[[@r12]\]. Surveillance studies should be continued to detect any changes in antimicrobial resistance of the normal flora of the intestinal tracts of companion animals. Our follow-up studies will address the presence of antimicrobial resistance genes harbored by resistant isolates.
